Olinvo: Ph III APOLLO-1 data

Top-line data from the double-blind, U.S. Phase III APOLLO-1 trial in 389 patients with moderate to severe acute pain following bunionectomy showed that 0.1, 0.35 and 0.5 mg doses of IV Olinvo as need...